Publications

1. Zhou J, Williams C, Staplin N, Judge PK, Mayne KJ, Agrawal N, Arimoto R, Green JB, Cherney DZI, Tuttle KR, Leal J, Clarke P, Emberson JR, Preiss D, Wanner C, Landray MJ, Baigent C, Haynes R, Herrington WG, Mihaylova B, EMPA-KIDNEY Collaborative Group. Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial. EClinicalMedicine. 2025 Jul; 85:103338 Epub 2025 July 08
   View PubMed
2. Davis A, Davis K, Moore E, Samuelson B, Stonerock L, Miller NE. Evaluation of Interprofessional Delivery of Diabetes Medication Management Training Among Family Medicine Residents. J Prim Care Community Health. 2024 Jan-Dec; 15:21501319241276801
   View PubMed
3. Herges JR, Herges LB, Dierkhising RA, Mara KC, Davis AZ, Angstman KB. Effect of Postdismissal Pharmacist Visits for Patients Using High-Risk Medications. Mayo Clin Proc Innov Qual Outcomes. 2018 Mar; 2 (1):4-9 Epub 2018 Feb 01
   View PubMed
4. Riad FS, Davis AM, Moranville MP, Beshai JF. Drug-Induced QTc Prolongation. Am J Cardiol. 2017 Jan 15; 119 (2):280-283 Epub 2016 Oct 08
   View PubMed
5. Haag JD, Davis AZ, Hoel RW, Armon JJ, Odell LJ, Dierkhising RA, Takahashi PY. Impact of Pharmacist-Provided Medication Therapy Management on Healthcare Quality and Utilization in Recently Discharged Elderly Patients. Am Health Drug Benefits. 2016 Jul; 9 (5):259-68
   View PubMed